Astrana Health, Inc. to Participate in Upcoming Investor Conference
Rhea-AI Summary
Astrana Health (NASDAQ: ASTH) has announced its participation in the upcoming J.P. Morgan 2025 Healthcare Conference in San Francisco. The company's President and CEO, Brandon Sim, is scheduled to deliver a presentation on Tuesday, January 14, 2024, at 10:30 AM PT.
As a provider-centric, technology-powered healthcare company focused on delivering accessible, high-quality, and high-value care, Astrana will make the webcast link and presentation materials available through the 'IR Calendar' section of their corporate website at https://ir.astranahealth.com/news-events/ir-calendar.
Positive
- None.
Negative
- None.
News Market Reaction – ASTH
In the trading session that priced this news, ASTH declined 3.96%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Astrana Health, Inc.
Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.
Headquartered in
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
Asher Dewhurst, ICR Healthcare
investors@astranahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-to-participate-in-upcoming-investor-conference-302336639.html
SOURCE Astrana Health, Inc.